Topics
ONE TIME EVENT
The Value of Biosimilar Trastuzumab in the Treatment of HER2 Positive Breast Cancer.
ONE TIME EVENT
Current Landscape of Biomarker Testing in Lung Cancer
ONE TIME EVENT
Emerging Role of PI3Ka Inhibitor in HR+ HER2- aBC: #ANewHope for Breast Cancer
ONE TIME EVENT
Updates on the Management of Metastatic Cancers
ONE TIME EVENT
Oncology Summit: Expanding our Cancer Treatment Spectrum